Log In
Print this Print this

Seprehvir (HSV1716)

  Manage Alerts
Collapse Summary General Information
Company Virttu Biologics Ltd.
DescriptionMutant HSV type 1 with a deletion in the RL1 gene
Molecular Target
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today